Approximately 200 years ago, James Parkinson had described the major symptoms of a disease that ultimately came to stand his name, i.e. Parkinson’s disease (PD). Gradually but definitely, our understanding about the disease has got enhanced, still the effective treatment for the disease has not yet been developed. PD leftovers an enormous challenge to those who suffer from it and to those concerned with its supervision. In addition to the problems common to other disabling neurological conditions, the management of PD must take into account the fact that the foundation of pharmacological treatment, levodopa, can ultimately produce dyskinesia, also called drug induced dyskinesia and motor fluctuation. Moreover, there are a number of agents besides levodopa that can help in the management of PD, and there is tempting but unverified prospect that other treatments might protect against worsening neurological disability. Moreover, in developing countries the marketed levodopa preparation is not accessed by individuals suffering from PD. Thus, a substantial amount of judgement is necessary in tailoring individual therapy and in timing treatment initiation.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Approximately 200 years ago, James Parkinson had described the major symptoms of a disease that ultimately came to stand his name, i.e. Parkinson's disease (PD). Gradually but definitely, our understanding about the disease has got enhanced, still the effective treatment for the disease has not yet been developed. PD leftovers an enormous challenge to those who suffer from it and to those concerned with its supervision. In addition to the problems common to other disabling neurological conditions, the management of PD must take into account the fact that the foundation of pharmacological treatment, levodopa, can ultimately produce dyskinesia, also called drug induced dyskinesia and motor fluctuation. Moreover, there are a number of agents besides levodopa that can help in the management of PD, and there is tempting but unverified prospect that other treatments might protect against worsening neurological disability. Moreover, in developing countries the marketed levodopa preparation is not accessed by individuals suffering from PD. Thus, a substantial amount of judgement is necessary in tailoring individual therapy and in timing treatment initiation. 76 pp. Englisch. N° de réf. du vendeur 9786138111825
Quantité disponible : 2 disponible(s)
Vendeur : Books Puddle, Woodside, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26404342716
Quantité disponible : 4 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 409892963
Quantité disponible : 4 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. PRINT ON DEMAND. N° de réf. du vendeur 18404342710
Quantité disponible : 4 disponible(s)
Vendeur : Revaluation Books, Exeter, Royaume-Uni
Paperback. Etat : Brand New. 76 pages. 8.66x5.91x0.18 inches. In Stock. N° de réf. du vendeur zk6138111826
Quantité disponible : 1 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Rai Sachchida NandSachchida Nand Rai is a Research Scholar, Department of Biochemistry, Institute of Science Banaras Hindu University, Varanasi Uttar Pradesh, India. He has published several research papers in SCI and PubMed-indexed . N° de réf. du vendeur 385846426
Quantité disponible : Plus de 20 disponibles
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Approximately 200 years ago, James Parkinson had described the major symptoms of a disease that ultimately came to stand his name, i.e. Parkinson's disease (PD). Gradually but definitely, our understanding about the disease has got enhanced, still the effective treatment for the disease has not yet been developed. PD leftovers an enormous challenge to those who suffer from it and to those concerned with its supervision. In addition to the problems common to other disabling neurological conditions, the management of PD must take into account the fact that the foundation of pharmacological treatment, levodopa, can ultimately produce dyskinesia, also called drug induced dyskinesia and motor fluctuation. Moreover, there are a number of agents besides levodopa that can help in the management of PD, and there is tempting but unverified prospect that other treatments might protect against worsening neurological disability. Moreover, in developing countries the marketed levodopa preparation is not accessed by individuals suffering from PD. Thus, a substantial amount of judgement is necessary in tailoring individual therapy and in timing treatment initiation. N° de réf. du vendeur 9786138111825
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Approximately 200 years ago, James Parkinson had described the major symptoms of a disease that ultimately came to stand his name, i.e. Parkinson¿s disease (PD). Gradually but definitely, our understanding about the disease has got enhanced, still the effective treatment for the disease has not yet been developed. PD leftovers an enormous challenge to those who suffer from it and to those concerned with its supervision. In addition to the problems common to other disabling neurological conditions, the management of PD must take into account the fact that the foundation of pharmacological treatment, levodopa, can ultimately produce dyskinesia, also called drug induced dyskinesia and motor fluctuation. Moreover, there are a number of agents besides levodopa that can help in the management of PD, and there is tempting but unverified prospect that other treatments might protect against worsening neurological disability. Moreover, in developing countries the marketed levodopa preparation is not accessed by individuals suffering from PD. Thus, a substantial amount of judgement is necessary in tailoring individual therapy and in timing treatment initiation.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 76 pp. Englisch. N° de réf. du vendeur 9786138111825
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Parkinson's disease and Mucuna Magic | Sachchida Nand Rai (u. a.) | Taschenbuch | 76 S. | Englisch | 2018 | LAP LAMBERT Academic Publishing | EAN 9786138111825 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 112514383
Quantité disponible : 5 disponible(s)